PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 41: Articles 20001-20500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Contraception in young people. [Antikoncepcia u mladistvych.]
  2. The oral contraceptive and hyperprolactinemic amenorrhea.
  3. Oral contraceptive formulations--influence on user compliance and reliability of the method.
  4. The oral contraceptive PPI: its effect on patient knowledge, feelings, and behavior.
  5. Oral contraceptive use and fibrocystic breast disease of different histologic classifications.
  6. Oral contraceptive use and the risk of breast cancer in young women.
  7. Oral contraceptives and acute viral hepatitis. [Anticonceptivos orales y hepatitis virica aguda.]
  8. Oral contraceptives and arterial disease--recent evidence from the Royal College of General Practitioners Oral Contraception Study.
  9. Oral contraceptives and benign tumors of the liver.
  10. Oral contraceptives and breast cancer rates [letter]
  11. Oral contraceptives and breast cancer.
  12. Oral contraceptives and breast cancer.
  13. Oral contraceptives and breast tumors: which pill? [Contraccettivi orali e tumori della mammella: quale pillola?]
  14. Oral contraceptives and breast-cancer rates [letter]
  15. Oral contraceptives and cancer.
  16. Oral contraceptives and cancer: a perspective.
  17. Oral contraceptives and cardiovascular disease--aspects of lipid metabolism. [P-piller och hjart-karlsjukdom--lipidmetabola aspekter.]
  18. Oral contraceptives and cardiovascular mortality. [Contraceptifs oraux et mortalite cardiovasculaire.]
  19. Oral contraceptives and lipoproteins.
  20. Oral contraceptives and neoplasia.
  21. Oral contraceptives and reproductive mortality [letter]
  22. Oral contraceptives and reproductive mortality [letter]
  23. Oral contraceptives and six benign liver tumors--the mestranol question [letter]
  24. Oral contraceptives and stroke.
  25. Oral contraceptives and stroke: findings in a large prospective study.
  26. Oral contraceptives and surgery: reduced antithrombin and antifactor Xa levels without postoperative venous thrombosis in low-risk patients.
  27. Oral contraceptives and venous thrombosis [letter]
  28. Oral contraceptives and venous thrombosis. Dr Kelly replies [letter]
  29. Oral contraceptives CBD Haora project: rural women take to the pill.
  30. Oral contraceptives containing chlormadinone acetate and cancer incidence at selected sites in the German Democratic Republic--a correlation analysis.
  31. Oral contraceptives in 1984.
  32. Adolescent use of oral contraceptives.
  33. Adolescents' communication styles and learning about birth control.
  34. Adolescents' reproductive rights: abortion, contraception, and sterilization.
  35. Advances in oral contraception. Advantages of a levonorgestrel containing 3-phase preparation over low-dose levonorgestrel and desogestrel containing monophasic combination preparations. [Fortschritte in der oralen Kontrazeption. Vorteile eines Levonorgestrel-haltigen Dreistufenpraparates gegenuber niedrigdosierten Levonorgestrel- und Desogestrel-Haltigen monophasischen Kombinationspraparaten.]
  36. Advances in research on the steroid contraceptives.
  37. Advertising family planning in the press: direct response results from Bangladesh.
  38. Advice on contraceptive measures at the time of abortion: optimal time and reduced effectiveness. [Kontrazeptionsberatung nach Schwangerschaftsabbruch.]
  39. Africa Region Planned Parenthood and Women's Development Programme: report of the December 1983 Anglophone Project Manager's Workshop.
  40. After effects of contraceptive sterilization in rural Bangladesh.
  41. Aged gametes, adverse pregnancy outcomes and natural family planning. An epidemiologic review.
  42. AID's population policies and programs and the place of contraceptive social marketing.
  43. All contraceptives have problems: toxic-shock syndrome and the vaginal contraceptive sponge.
  44. An all-in-one birth control pill, abortifacient, Cushings's treatment?
  45. Alpha-fetoprotein assay in patients treated with low-dose oral contraceptives.
  46. Alteration of platelet responses to metabolites of arachidonic acid by oral contraceptives.
  47. Alterations in prednisolone disposition as a result of oral contraceptive use and dose.
  48. Alternatives: family planning service delivery program in an urban Haitian slum.
  49. Amenorrhea following the administration of oral contraceptives. [Amenorrea despues de la administracion de contraceptivos orales.]
  50. Amenorrhea in selected developing countries: estimates from Contraceptive Prevalence Surveys.
  51. Analysis of multi-faceted assignment for Cairo Family Planning Association.
  52. Androgenic action of progestins used in oral contraceptives.
  53. Androgenisation of female partners of men on medroxyprogesterone acetate/percutaneous testosterone contraception [letter]
  54. Annotated bibliography of population/family planning: Colombia. [Bibliografia anotada sobre poblacion/planificacion familiar.]
  55. Annotated bibliography on population/family planning--Colombia. [Bibliografia anotada sobre poblacion/planificacion familiar--Colombia.]
  56. Anordrin: biologic studies and potential as a long-acting contraceptive.
  57. Antibody studies may lead to a vaccine contraceptive.
  58. Application of Lorenz curve to interpret concentration of contraception and fertility in a population.
  59. Are there any absolute medical contraindications to the progestogen only oral contraceptive? [letter]
  60. The art of contraceptive counselling.
  61. Arterial occlusion in the ocular fundus induced by oral contraceptives. [Oralis anticoncipiens szedese soran kialakult szemfeneki arterias occlusio.]
  62. Aspects of the choice of contraceptives after legal abortion in relation to psychological masculinity-femininity and psychosocial functions.
  63. Family planning through development [in Sri Lanka]
  64. The family planning work as suggested by analysis of the age at first marriage in Jiaxing Prefecture, Zhejiang Province.
  65. Family planning, the Lebanese experience. A study on the Lebanese Family Planning Association.
  66. Family planning--the role of the nurse/midwife in Britain in 1984.
  67. Family planning.
  68. Family planning. [Planificacion familiar.]
  69. Family planning. A most effective preventive health measure.
  70. Family planning: a nurse's concern.
  71. Family planning: a peoples' movement.
  72. Family planning: a preventive health measure.
  73. Family planning: an adaptive strategy. (A case study from West Bengal)
  74. Family planning: client counselling and public education.
  75. Family planning: ethical and legal aspects. [Planejamento familiar: aspectos eticos e legais.]
  76. Family planning: expansion and integration.
  77. Family planning: helping men ask for help.
  78. Family welfare and population trends--an integrated approach to family welfare. The health team approach to planned parenthood III. Report.
  79. Fecundity, fertility and contraceptive choice: the demand and supply of births.
  80. Female education, family planning, income, and population: a long-run econometric simulation model.
  81. Female urethral pressure profile; reproducibility, axial variation and effects of low dose oral contraceptives.
  82. The Femcept system: non surgical permanent contraception for the female. [Le systeme Femcept. Contraception permanente pour femmes sans chirurgie.]
  83. The feminist position on family planning in Spain.
  84. Fertile inventions: new contraceptive techniques.
  85. Fertility and characteristics of ovulation after discontinuing oral contraception. [Fertilite et qualite ovulaire apres arret de la contraception orale.]
  86. Fertility and family planning among the Bangkok slums.
  87. Fertility and family planning in Papua New Guinea.
  88. Fertility and family planning practices in rural Bangladesh.
  89. Fertility and family planning.
  90. Fertility and the use of contraception among the rural Coloured: 1971 and 1980. [Fertiliteit en kontraseptiewe gebruik onder landelike Kleurlinge: 1971 en 1980.]
  91. Fertility awareness-means to an end with special reference to natural family planning.
  92. Fertility preferences and contraceptive use in the Philippines.
  93. Shared contraception.
  94. Shared sexual responsibility: a strategy for male involvement in United States Family Planning clinics.
  95. Should government "squeal" on teens seeking contraception?
  96. SHSTF's answer to the Abortion Committee: support patient and personnel and expand contraceptive counseling. [SHSTFs svar pa abortutredningen: stod patient och personal och bygg ut p-radgivningen.]
  97. Sickle cells and hormonal contraception.
  98. Side effects of oral contraceptives in Oriental women.
  99. A simple method for estimating the contraceptive prevalence required to reach a fertility target.
  100. Simulation modeling perspectives of the Bangladesh family planning and female education system.
  101. Six out of ten countries support family planning.
  102. Small-scale studies and field experiments in family planning in the Philippines.
  103. Smoking cessation with young women in public family planning clinics: the impact of physician messages and waiting room media.
  104. Social and demographic factors in a causal model of attitudes toward pregnancy, contraceptive use, and pregnancy outcomes.
  105. Social class, religion and contraceptive failure in a sample of pregnant women in Brisbane.
  106. Social communication, organization and community development. Family planning in Thailand.
  107. A social judgment study of college students' attitudes toward premarital contraceptive use.
  108. Social marketers' lack of success in using CSM discipline to harness commercial resources and increase contraceptive prevalence.
  109. Social marketing of contraceptives in Bangladesh.
  110. Socio-economic and demographic differentials among eligible women of reproductive age for treatment and comparison areas of the Family Planning Health Services Project, Matlab.
  111. Socio-economic and demographic factors and their influence on family planning behaviour among non-adopters.
  112. Socio-economic correlates of fertility and contraceptive practices amongst target couples of a rural community.
  113. The socioeconomic and demographic factors influencing contraceptive behavior in Kenya.
  114. Some aspects of sexual knowledge and sexual behaviour of local women. Results of a survey. 1. General sexual knowledge and attitude to abortion, pregnancy and contraception.
  115. Some attitudes of black opinion leaders toward family planning and the National Family Planning Programme.
  116. Some characteristics of contraception in the private sector. [Quelques caracteristiques de la contraception dans le secteur prive.]
  117. Some issues in family planning [draft]
  118. Some observations on family planning education in China.
  119. Some organizational alternatives to increase support for reproductive and contraceptive research.
  120. The South African national family-planning programme: contraceptive protection and service efficiency during April 1981.
  121. Spatial and temporal aspects of contraceptive adoption: an analysis of contemporary fertility behavior in Costa Rica.
  122. Sri Lanka: an innovative approach to the implementation of integrated parasite control, nutrition and family planning projects.
  123. Statement of the Planned Parenthood Federation of America, Inc.
  124. Statement on steroidal oral contraception.
  125. The statistical evaluation of natural methods of family planning.
  126. The 11th Asian Parasite Control/Family Planning Conference proceedings.
  127. 1980 population and housing census. Subject report No. 3. Fertility and family planning.
  128. A 1984 perspective of contraceptive technology.
  129. 3D display of stillbirth in Indonesian obstetrics. Part 4: Contraception as preventive determinant?
  130. 8 in 10 Khartoum men favor contraception for spacing children.
  131. Acceptability and discontinuation of family planning methods: some methodological aspects. [Aceptabilidad y discontinuidad de los metodos de planificacion familiar: algunos aspectos metodologicos.]
  132. The acceptability of household distribution of contraceptives in Zaire.
  133. Acceptability of laparoscopic tubal ligation by Fallope ring when available among other family planning methods in rural Egypt.
  134. Acceptability study of the two versus three monthly injectable contraceptives.
  135. Acceptance of effective contraceptive methods after induced abortion.
  136. Accessibility of family planning, community development and their impact on the birth rate of rural Philippines.
  137. Achievement of the national family planning program: press conference.
  138. The achievements in family planning work in Rudong County as suggested by the data of the Fertility Survey.
  139. Action now in family planning: the role of nurse.
  140. Active users vs. couple-months-of-protection: the comparability of two indicators of performance in family planning programs.
  141. Acute dyspnea in a young woman taking birth control pills.
  142. Adapting the training and visit system for family planning, health, and nutrition programs.
  143. Adolescent and family planning.
  144. Adolescent contraception.
  145. Adolescent contraception. [Anticoncepcao na adolescencia.]
  146. Adolescent contraceptive use and pregnancy: the role of the male partner.
  147. Assessment of infant mortality, childhood mortality and family planning targets from fertility data.
  148. Assessment of knowledge and attitudes of high school students regarding family planning: a need of the day.
  149. Assessment of the logistics associated with the use of Depo-Provera in Jamaica through the National Family Planning Board.
  150. The association between smoking and sexual behavior among teens in US contraceptive clinics.
  151. Assuring the safety of men and women in family planning services. [Assurer la securite de l'homme et de la femme dans les services de planification de la famille.]
  152. Attitudes and behavior of physicians and medical students towards contraception: results of a study carried out in Modena. [Atteggiamenti e comportamenti di medici e studenti in medicina di fronte alla contraccezione: i risultati di una indagine effettuata a Modena.]
  153. Attitudes of a group of Egyptian medical students towards family planning.
  154. The attitudes of sterilized women to contraceptive sterilization.
  155. Attitudes toward family planning.
  156. Australian Council of Natural Family Planning.
  157. The availability of contraceptive services.
  158. Bangladesh National Contraceptive Prevalence Survey--1983: key results.
  159. Bankruptcy of contraception. [Het failliet van de anticonceptie?]
  160. Barrier contraception.
  161. Barrier methods of contraception.
  162. Barrier methods of contraception.
  163. Baseline study for an information campaign on wanted births in Zaire. Volume II. Synthesis of research on contraception and communication in Zaire. [Etude de base pour une campagne d'information sur les naissances desirables au Zaire. Volume II. Synthese de recherches sur la contraception et la communication au Zaire.]
  164. Basic considerations in the choice of contraceptive methods for male and female. [Grundsatzliche Betrachtungen zur Wahl der Methode bei Mann und Frau.]
  165. Basic information on family planning for nurses, pharmacists, social workers and all who may be asked for advice.
  166. Benefits and risks of hormonal contraception--interpretation.
  167. Benign breast disease, oral contraceptive use, and the risk of breast cancer [letter]
  168. Benign hepatic adenoma associated with oral contraceptive use mimicking pelvic inflammatory disease: a case report.
  169. Benzalkonium chloride--a new vaginal contraceptive.
  170. Beta-adrenoceptor blocker pharmacokinetics and the oral contraceptive pill.
  171. Beyond family planning measures.
  172. Beyond family planning in Indonesia.
  173. Beyond family planning: case study of the Village Family Planning/Mother Child Welfare Project, USAID/Jakarta.
  174. Bibliography on: family health, family planning, primary health care, health education. [Bibliography sur: sante de la famille, planification familiale, soins de sante primaires, education pour la sante.]
  175. The Billings method of family planning: an assessment.
  176. Biphasic oral contraceptives.
  177. The birth and development of the pill; a short history of oral contraception.
  178. Birth control ads: censors practice double standards.
  179. Birth control and family planning in New Zealand: an annotated bibliography.
  180. Birth control discontinuance as a diffusion process.
  181. Birth control guide at a glance.
  182. Birth control in the Third World countries and its needs for new biotechnology.
  183. Birth control methods for men [tables]
  184. Births averted under family planning programme: a mathematical approach.
  185. Black women in double jeopardy: a perspective on birth control.
  186. Breast cancer and oral contraceptives: critique of the proposition that high potency progestogen products confer excess risk.
  187. Breast cancer, cervical cancer, and depot medroxyprogesterone acetate. [WHO Collaborative Study of Neoplasia and Steroid Contraceptives] [letter]
  188. Breast feeding: fertility and contraception.
  189. Breast-feeding, postpartum abstinence and contraception in Lagos, Nigeria.
  190. Breastfeeding as a contraceptive method. Part 2: the epidemiology of post-partum amenorrhea. [L'allaitement maternel, moyen de contraception. 2eme partie: epidemiologie de l'amenorrhee post-partum.]
  191. Breastfeeding, a contraceptive method? Part 3: comparison between breastfeeding and modern contraceptive methods. [L'allaitement maternel, moyen de contraception? 3eme partie: comparaison de l'allaitement maternal avec les methodes modernes de contraception.]
  192. Brief background paper on male involvement in family planning.
  193. A brief introduction to China's family planning programme.
  194. Buhari advocates family planning.
  195. Building on what works: malaria volunteer workers delivering family planning and primary health care in rural Haiti.
  196. Cafeteria contraception in China: some pharmacological novelties.
  197. Calcium oxalate crystal growth in normal urine: role of contraceptive hormones.
  198. Can effective birth control be legislated? An analysis of factors that predict birth control utilization.
  199. Cancer chemotherapy and contraceptive counseling.

     

  200. Capacitation of midwives in family planning.
  201. Carbohydrate metabolism alterations with monophasic, sequential and triphasic oral contraceptives containing ethinyl-oestradiol plus levonorgestrel or desogestrel.
  202. Cardiovascular disease mortality trends in Denmark before and after the introduction of oral contraceptives. [Dodelighed af kardiovaskulaere sygdomme i Danmark for og efter indforelsen af p-piller.]
  203. Cardiovascular diseases and oral contraception. Study of cases and controls. [Enfermedades cardiovasculares y anticoncepcion oral. Estudio de casos y controles.]
  204. Caribbean contraceptive social marketing project, a project of the Futures Group: progress report.
  205. A case of multiple thromboses: review of the cardiovascular complications of oral contraceptives. [A propos d'un cas de thromboses multiples: revue des complications cardio-vasculaires des contraceptifs oraux.]
  206. A case study of factors contributing to a rapid increase in contraceptive prevalence in a low prevalence union.
  207. The case study of Harrisons & Crosfield Estates, a family planning services in the private sectors, in Malaysia (Part I.)
  208. A case-control study of oral contraceptive use and breast cancer.
  209. CBD: much more than community based distribution of contraceptives. [DCA: mucho mas que distribucion comunitaria de anticonceptivos.]
  210. Cerebral arterial occlusion and intracranial venous thrombosis in a woman taking oral contraceptives.
  211. Characteristics of contraceptive acceptors in an urban Nigerian setting.
  212. China: the strengthening of family planning at grass-roots level.
  213. The choice of oral contraception in 1984: general indications and specific cases. [Le choix d'une contraception orale en 1984: indications generales et cas particuliers.]
  214. Choices in contraception.
  215. Choosing an oral contraceptive.
  216. Christianity and family planning in Africa with special reference to Catholicism.
  217. Classic methods of contraception. [Die klassischen Methoden der Kontrazeption.]
  218. The climacteric. Contraceptive needs of the middle-aged couple.
  219. Clinic-based family planning in Senegal: the 1983 "Vanguard Contraceptors" Study, Dakar.
  220. Clinical and experimental evaluation of a new vaginal contraceptive.
  221. Clinical evaluation of Rigevidon used for contraception. [Kliniczna ocena rigevidonu stosowanego w celach antykoncepcyjnych.]
  222. The clinical laboratory as a source of income within a family planning program. [El laboratorio clinico como fuente de ingresos economicos dentro de un programa de planificacion familiar.]
  223. Clinical study of the secondary effects associated with taking a triphasic anti-ovulatory contraceptive. [Etude clinique des effets secondaires lies a la prise d'un complexe antiovulatoire triphasique.]
  224. Clinical trial of the monthly injectable contraceptives Cycloprovera and HRP 102.
  225. Clinically silent polymicrobial amnionitis and intrauterine fetal death associated with a Cu-7 intrauterine contraceptive device.
  226. Clinicians, patients fight rising costs of contraception.
  227. Colombia: demographic transition and family planning. [Colombia: transicion demografica y planificacion familiar.]
  228. Combining research techniques in the study of fertility and family planning in Java: theory and practice.
  229. Comment on an article, "Absence of correlation between oral contraceptive usage and cardiovascular mortality".
  230. Comment on an article, "Absence of correlation between oral contraceptive usage and cardiovascular mortality".
  231. Communicating contraception.
  232. Community and family planning: a statistical analysis of Egyptian data.
  233. Community participation in family planning: a consultation between researchers, practitioners and support agencies.
  234. Community participation in family planning: rhetoric and reality. [Participacion de la comunidad en la planificacion familiar: retorica y realidad.]
  235. Comparative evaluation of contraceptive efficacy of norethisterone oenanthate (200 mg) injectable contraceptive given every two or three monthly.
  236. A comparative study of adolescent family planning compliance with two different referral approaches.
  237. Comparative study of lipid metabolism and endocrine function in women receiving levonorgestrel- and desogestrel-containing oral contraceptives.
  238. Comparison of baseline and round III surveys in 12 villages in Menoufia Governorate, Egypt: an evaluation of family planning and health interventions.
  239. A comparison of three social-psychological models of attitude and behavioral plan: prediction of contraceptive behavior.
  240. Contraception survey in the villages of Siklos district of Baranya county. [Fogamzasgatlasi vizsgalat Baranya megye siklosi jarasanak kozsegeiben.]
  241. Contraception through immunization and regulation of luteal function.
  242. Contraception update.
  243. Contraception using normal dose progestins. [La contraception par les progestatifs normodoses.]
  244. Contraception with a levonorgestrel-releasing IUD: effect on lactation and child development.
  245. Contraception with an LHRH agonist: effect on gonadotrophin and steroid secretion patterns.
  246. Contraception with progesterone pellets during lactation. [Anticoncepcion con pellets de progesterona durante la lactancia.]
  247. Contraception with single implants and mini-implants of ST-1435.
  248. Contraception--the morning after.
  249. Contraception: answers of wives and husbands compared in a survey of Swiss couples.
  250. Contraception: fad and fashion.
  251. Contraception: helping patients choose.
  252. Contraception: the facts.
  253. Contraception? No, but we're careful.
  254. Contraceptive advice for the postpartum period. [Conseils contraceptifs pour le postpartum.]
  255. Contraceptive agents for men. [Antifertilini agensi u muskarca.]
  256. Contraceptive attitudes and practice in women choosing sterilization.
  257. Contraceptive behavior in 1877 clinic patients. Which methods to use? What were the motives for their discontinuation? [Il comportamento contraccettivo in 1877 utenti di consultorio. Quali percorsi? Quali i motivi della sospensione?]
  258. Contraceptive behaviour in Swedish women--a follow-up study.
  259. The contraceptive benzalkonium chloride tampon. [Le tampon contraceptif au chlorure de benzalkonium.]
  260. Contraceptive continuation in rural Egypt.
  261. Contraceptive counselling in adolescence.
  262. Contraceptive development for the future. [La contraception de l'avenir.]
  263. Contraceptive discontinuation in Egypt: a dilemma of high availability and brief use.
  264. Contraceptive discontinuation in Egypt: differentials and determinants of length of use.
  265. Contraceptive distribution requirements and the loss of family planning acceptors.
  266. The contraceptive effect of the pill is not mediated by the quality of the peritoneal fluid.
  267. Contraceptive effectiveness in Mexico.
  268. Contraceptive effectiveness: some methodological propositions. [Efficacite de la contraception: propositions methodologiques.]
  269. The contraceptive mentality and abortion.
  270. Contraceptive method mix: what determines program and individual user preferences?
  271. Contraceptive methods in Venezuela. [Metodos anticonceptivos en Venezuela.]
  272. Contraceptive patterns of religious and racial groups in the United States, 1955-76: convergence and distinctiveness.
  273. Contraceptive pill use, urinary sodium and blood pressure. A population study in two Belgian towns.
  274. Contraceptive pills and cancer (letter) [P-piller og cancer.]
  275. Contraceptive plans and postpartum sterilization.
  276. Contraceptive potential of analogs of LH-RH.
  277. Contraceptive practice in the population program: the latest information from Indonesia. [Pemakaian kontrasepsi dan perkembangan program: informasi baru dari Indonesia.]
  278. Contraceptive practices and reproductive patterns in sickle cell disease.
  279. Contraceptive prevalence in selected slums of Rio de Janeiro: results of an operations research project.
  280. Contraceptive product advertising.
  281. Contraceptive risk-taking behavior among young women: an investigation of psychosocial variables.
  282. Contraceptive self-efficacy: a primary prevention strategy.
  283. A contraceptive social marketing (CSM) program needs continuity of management: the Asociacion Demografica Salvadorena (ADS) in 1983] [letter.
  284. Contraceptive social marketing in three Eastern Caribbean countries. A report of the First Monitoring Survey.
  285. Contraceptive sponge patient insert warns of TSS.
  286. Contraceptive technologies for the future.
  287. Contraceptive technology 1984-1985. 12th rev. ed.
  288. Contraceptive technology from the administrator's perspective. [La tecnologia anticonceptiva desde la perspectiva del administrador.]
  289. Contraceptive technology.
  290. Contraceptive trends.
  291. Contraceptive use among women with sickle cell diseases, Accra, Ghana.
  292. Contraceptive use and fertility in the Commonwealth Caribbean.
  293. Contraceptive use and nonuse by sexually active teenagers: a qualitative study, rev. ed.
  294. Contraceptive use in China.
  295. Contraceptive use, pregnancy and fertility patterns among single women, 1983 [draft]
  296. Contraceptives and their politics.
  297. Contraceptives, pregnancy, and systemic lupus erythematosus. [Antikonzeption und Graviditat bei systemischem Lupus erythematodes.]
  298. Controlled release of contraceptive agents from poly(ortho esters)
  299. Coordination aspects of the Indonesian family planning program.
  300. Coordination in multifactor programs: an empirical investigation of factors affecting coordination among organizations at the local level in the Egyptian family planning program.
  301. Correlation of moral development with use of birth control and pregnancy among teenage girls.
  302. The costs and benefits of Title XX and Title XIX family planning services in Texas.
  303. Cotton seed oil for birth control.
  304. Counseling for voluntary surgical contraception. Guidelines for programs in the United States.
  305. A covariance structure analysis of contraceptive behavior.
  306. Creative financing of family planning projects: can programs pay for themselves?
  307. Critique of the bourgeois theory of family planning. Bourgeois demography. [Critica a la teoria burguesa sobre la planificacion familiar. Demografia burguesa.]
  308. Cross cultural analysis of natural family planning acceptors: preliminary report.
  309. Cross cultural family planning training at the Margaret Sanger Center, New York.
  310. A crucial new direction for international family planning.
  311. Current concepts of the effect of contraceptives on the oral cavity and especially on the periodontal tissues. [Eugchrones apopseis gia ten epidrase ton antisyllgeptikon ste stomatike koiloteta kai kyrion stous periodontikous istous]]
  312. Current fertility control discussion on oral contraceptives.
  313. Current methods of contraception. [Methodes de contraception actuelle.]
  314. Current perspectives on combination oral contraceptives.
  315. Current research into oral contraception in Singapore.
  316. The Dalkon Shield case: a plea for corporate conscience. [INTERNATIONAL REVIEW OF NATURAL FAMILY PLANNING.]
  317. Danazol use, contraception [letter]
  318. Danazol use, contraception [letter]
  319. Data for commentary on voluntary surgical contraception in Latin America [tables]
  320. Decision-making and diffusion in family planning.
  321. Decision-making in regard to the use of contraceptives after confinement: a study among urban black women.
  322. Decreased plasma phosphate under hormonal contraceptives.
  323. Delivering sex education and family planning services to young people in Guatemala, C.A.
  324. Delivery of a new vaginal contraceptive.
  325. Demand for physician training in family planning: Piaui State, Brazil.
  326. Demographic and contraceptive patterns among women in Northern Mindanao, The Philippines.
  327. The design of a sample registration system for monitoring demographic dynamics and health and family planning service operations in rural Bangladesh.
  328. Detection of Neisseria gonorrhoeae in cervical swabs using the Gonozyme enzyme immunoassay. Clinical evaluation in a university family planning clinic.
  329. Determinants of contraceptive use in rural Bangladesh: an examination of the demand for children, the supply of children, and cost of regulation factors.
  330. Determinants of fertility in Bangladesh: desired family size, natural fertility, and contraceptive use.
  331. Determinants of the high prevalence of grandmultiparity and impact of counselling on contraceptive acceptance.
  332. Determination of fructose in sperm: application in the monitoring of a male hormonal contraceptive. [Dosage du fructose dans le sperme application a la surveillance d'une contraception hormonale masculine.]
  333. Developing a comprehensive strategy for integrated health and family planning delivery.
  334. Developing an African regional training capability in contraception and family planning program management.
  335. Developing family planning nurse practitioner protocols.
  336. The development and current organisation of the family planning programme.
  337. Development of a low-dose monthly injectable contraceptive system: I. Choice of compounds, dose and administration route.
  338. Development of a scale to measure attitude toward the condom as a method of birth control.
  339. Development of certain levonorgestrel esters as long-acting injectable contraceptives.
  340. The development of GS-I type contraception flower.
  341. The development of hormonal contraception in the Hungarian People's Republic. [Razvitie gormonal'hnoi Kontratsepsii v Vengerskoi Narodnoi Respublike.]
  342. Development of microencapsulated norgestimate as a long-acting contraceptive.
  343. Development of national natural family planning programs.
  344. Dialogue [response to TW Hilgers "The statistical evaluation of natural methods of family planning"] [letter]
  345. Different approaches in contraception.
  346. Differential contraceptive use among the slum and non-slum dwellers: a study of Hyderabad city.
  347. Differential effects of isoniazid and oral contraceptive steroids on antipyrine oxidation and acetaminophen conjugation.
  348. Differentials in contraceptive use.
  349. The diffusion of birth control in Germany, 1871-1933.
  350. Digestive complications of oral contraceptives: a case of extensive digestive necrosis in a young woman. [Les accidents digestifs des contraceptifs oraux: un cas de necrose digestive etendue chez une femme jeune.]
  351. Directive of the Central Committee of the Chinese Communist Party on family planning work [abstract]
  352. Discussion: acceptability of long-acting contraception.
  353. Discussion: injectable/implantable long-acting contraceptive delivery systems.
  354. Discussion: long-acting contraceptive delivery systems: additional clinical studies.
  355. Discussion: long-acting contraceptive delivery systems: clinical studies.
  356. Discussion: long-acting vaginal contraceptive delivery systems.
  357. Discussion: polymeric delivery systems for contraception.
  358. Disposition of clotiazepam: influence of age, sex, oral contraceptives, cimetidine, isoniazid and ethanol.
  359. Do oral contraceptives reduce the incidence of rheumatoid arthritis? A pilot study using the Stockholm County Medical information system.
  360. Do's and don'ts for a woman who has an abnormal lipid pattern and is taking oral contraceptives. [Faites...ne faites pas...devant une femme sous contraception oestroprogestative ayant un bilan lipidique anormal.]
  361. Doctors, birth control, and social values, 1830-1970.
  362. Dominican Republic. National Contraceptive Prevalence Survey. Women. Report of Findings. [Republica Dominicana: Encuesta Nacional de Prevalencia del Uso de Anticonceptivos. Mujeres. Informe de resultados.]
  363. Doorstep administration of injectable contraceptives by the family welfare assistants in Abhoynagar upazila: a domiciliary injectable contraceptive programme.
  364. Double (uterine and ectopic) pregnancy of a patient using an intrauterine contraceptive device.
  365. Dr. Fielding replies [to Poma letter concerning unwanted pregnancy as a failure of contraceptive education] [letter]
  366. Dr. Fred Sai exhorts African medical leaders to implement family planning programs.
  367. Drug interaction between phenytoin and oral contraceptives [response to question]
  368. Drug interactions involving oral contraceptive steroid therapy.
  369. Drug interactions with contraceptive methods. [Influence de certains medicaments sur les differents procedes de contraception.]
  370. Drug interactions with oral contraceptive steroids.

     

  371. Drug interactions with oral contraceptive steroids. [Vzaimodeistvie na medikamenti s oralni kontratseptivni steroidi.]
  372. Early symptoms and discontinuation among users of oral contraceptives in Sri Lanka.
  373. Early symptoms and discontinuation among users of oral contraceptives in Sri Lanka.
  374. Ecological factors predicting adolescent contraceptive use: implications for intervention.
  375. Ecuador. Contraceptive Prevalence Survey. Summary. [Ecuador. Encuesta de Prevalencia del Uso de Anticonceptivos: resumen.]
  376. Educating peers about human sexuality and birth control in natural settings: a social comparison perspective.
  377. Education and counselling for voluntary surgical contraception.
  378. Educational communication in family planning. [Comunicacion educativa en planificacion familiar.]
  379. Effect of a new hormonal contraceptive (Neo-Eunomin) on androgenisation of the skin in women. [Wirkung eines neuen hormonalen Kontrazeptivums (Neo-Eunomin) bei Frauen mit Androgenisierungs-erscheinungen.]
  380. The effect of a progestogen-only oral contraceptive (Lynestrenol 0.5 mg) on lactation.
  381. The effect of a single midcycle administration of 0.5 or 2.0 mg dienogest (17alpha-cyanomethyl-17beta-hydroxy-estra-4, 9-dieu-3-one) on pituitary and ovarian function--investigation for the use as a postcoital contraceptive]
  382. Effect of a topical contraceptive on endocervical culture for Neisseria gonorrhoeae.
  383. The effect of chemical intravaginal contraceptives and betadine on Ureaplasma urealyticum.
  384. Effect of exercise and oral contraceptive agents on fibrinolytic potential in trained females.
  385. The effect of injectable contraceptive on lipid metabolism in women.
  386. Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation.
  387. The effect of long-term pregestational use of oral contraceptives on folacin nutriture during lactation and on levels of folacin in milk.
  388. Effect of low-dose oral contraceptives on lipoproteins and lipolytic enzymes: differences between two commonly used preparations.
  389. The effect of marital dissolution on contraceptive protection.
  390. Effect of oral contraception on serum bile acid.
  391. Effect of oral contraceptive on platelet aggregation, plasma fibrinogen, fibrinolytic activity in women.
  392. The effect of oral contraceptives on glucose tolerance.
  393. Effect of oral contraceptives on the nutrient profile of women belonging to high income group.
  394. Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics.
  395. Effect of religiosity on sex attitudes, experience nad contraception among university students.
  396. Effect of subdermal levonorgestrel contraceptive implants, Norplant, on liver function.
  397. Effect of subdermal levonorgestrel contraceptive, implants, Norplant, on serum lipids.
  398. Effects of a state family planning allocation formula.
  399. The effects of contraception on the dynamics of the family and the birth rate.
  400. Effects of family planning on maternal and child health.
  401. Effects of hormonal contraceptives on milk volume and infant growth.
  402. The effects of individual, village and program characteristics on contraceptive use in rural Thailand.
  403. Experience in a local authority clinic concerning advice on contraception. A consecutive study of 1000 women consulting a clinic for contraceptive advice in the Municipality of Fredriksberg. [Erfaringer fra en amtskommunal klinik til vejledning om svangerskabsforebyggelse. En konsekutiv interviewundersogelse af 1.000 kvinder fra Frederiksberg kommunes klinik for radgivning om svangerskabsforebyggelse.]
  404. Experience of Norplant contraceptive implants in Sweden.
  405. Expert meeting on oral contraceptive needs of developing countries.
  406. External scintigraphy in the study of long-acting contraceptive delivery systems.
  407. Externalities, heterogeneity and the optimal distribution of public programs: child health and family planning interventions.
  408. Factor VII in plasma of women taking oral contraceptives. Lack of cold activation under blood bank conditions.
  409. Factors affecting the choice of nonpermanent contraceptive methods among married women.
  410. Factors affecting use and non-use of contraception.
  411. Factors associated with adolescent use of family planning clinics.
  412. Factors associated with apparent ineffectiveness of family planning efforts in Kenya--implications for primary health care.
  413. Factors limiting the provision of family planning services in urban Nepal.
  414. Factors related to perceptions of side effects by those using clinical contraception: a research study among black women in Daveyton. [Faktore wat verband hou met die persepsi van newe-effekte by gebruikers van kliniese kontraseptiewe: 'n eksploratiewe studie onder Swart vroue in Daveyton.]
  415. Facts about oral contraceptives.
  416. Failure of post-coital contraception after insertion of an intrauterine device. Case report.
  417. The family and the planning game: family, desired number of children, and family planning in Switzerland. [Planspiel Familie: Familie, Kinderwunsch und Familienplanung in der Schweiz.]
  418. Family planning acceptor characteristics study: the Gambia, 1976-1983.
  419. Family planning and demographic yearbook, 1983.
  420. Family planning and economic development in Shifang County.
  421. Family planning and health care for Cambodian refugees in the United States: an international perspective.
  422. Family planning and health: an evaluation.
  423. Family planning and human rights.
  424. Family Planning and Maternal/Child Health Survey, Guatemala 1983. Final English language report.
  425. Family planning and motherhood: experiences of women with multiple sclerosis.
  426. Family planning and population policy in Brazil.
  427. Family planning and population projections.
  428. Family planning and reproductive health: determinants and use of contraceptive methods among women exposed to high risk pregnancy.
  429. Family planning and sex education of young people: report on a WHO meeting, Copenhagen, 1-5 November 1982.
  430. Family planning and sexuality. [Planificacion familiar y sexualidad.]
  431. Family planning and STD programs: can their efforts be merged?
  432. Family planning and the commercial sector for contraceptive pills. [Planejamento familiar e setor comercial de anovulatorios.]
  433. Family planning and the quality of life.
  434. Family planning as a nutrition intervention in Zaire.
  435. The Family Planning Association of Hong Kong (FPAHK): male responsibility promotion.
  436. Family Planning Association of Kenya. Steps taken in Kenya to gain acceptance of family planning including voluntary surgical contraception.
  437. A family planning center--10 years experience. [Novedelmi tanacsado--10 ev tapasztalata tukreben.]
  438. Family planning centres, sex therapists and the courts.
  439. Family planning clinic discontinuation.
  440. Family planning education in developing nations.
  441. Family planning education: how do adults feel about it?
  442. Family planning experience.
  443. Family planning for health in Africa.
  444. Family planning for health in Africa: the executive summary and overview.
  445. Family planning health and population.
  446. Family planning in developing nations: a global concern, our concern.
  447. Family planning in Europe. [Planovani rodiny v Evrope.]
  448. Family planning in Goroka District 1976-1981.
  449. Family planning in India: pediatrician's view [abstract]
  450. Family planning in Lae urban area of Papua New Guinea 1981.
  451. Family planning in low-income communities of Bangkok.
  452. Family planning in Nigeria.
  453. Family planning in Portugal. How an information and education project was implemented.
  454. Family planning in slum areas research [tables]
  455. Family planning in Tana Toraja.
  456. Family planning in the framework of technical co-operation.
  457. Family planning in the service of human development.
  458. Family planning in the Socialist Republic of Croatia. [Trendovi planiranja obitelji u SR Hrvatskoj.]
  459. Family planning methods.
  460. The family planning movement within the African Region of the International Planned Parenthood Federation. Le mouvement pour la planification familiale dans la Region Afrique de la Federation Internationale pour la Planification Familiale.
  461. Family planning needs in Nigeria [letter]
  462. Family planning needs of adolescents.
  463. Family planning needs of and services for the underprivileged urban: the case of Bangkok. A proceedings of the Seminar/Workshop, 26-28 January 1984, Wongse Amataya Hotel, Cholburi Province.
  464. The family planning nurse. One. In the family way.
  465. Family planning operations research in Asia. Thirty month progress report. Period covered: 1 October 1981 - 31 March 1984.
  466. Family planning operations research: a decade of experience.
  467. Family planning organizations and 'abortion-related activities'.
  468. Family planning performance in India: a study of inter-state and inter-district differentials.
  469. Family planning policy issues in Taiwan, Republic of China.
  470. Family planning program effort and birthrate decline in developing countries.
  471. Family planning program users in Costa Rica, 1974-1980. [Las usuarias del programa de planificacion familiar en Costa Rica, 1974-1980.]
  472. The family planning programme at the local level: a study of a village area in South India.
  473. The family planning programme in India: the non-governmental sector.
  474. The family planning programme, education and development: a case study of Karnataka.
  475. Family planning programmes and fertility in Mexico.
  476. Family planning programs and contraceptive availability: their effects on contraceptive use and fertility.
  477. Family planning project of Block 12-Klong Toey slum.
  478. Family planning publicity and communication in China.
  479. Family planning research in Peru. [Investigacion en planificacion familiar en el Peru.]
  480. Family planning social product availability: some logistical problems and prospects in Bangladesh.
  481. Family planning statistics and the Tower of Babel. The challenges of gathering population and family planning data in a refugee camp.
  482. Family planning support materials for illiterate and semi-literate audiences in The Gambia: January 1983 to June 1984. Project report.
  483. Family planning survey among Blacks in the PWV area. [Gehooranalise met betrekking tot gesinsbeplanning onder Swartes in die PWV-gebied.]
  484. A family planning survey in Ireland.
  485. Family planning through community-based services.
  486. Fertility, contraception, and family planning in Mexico. [Fecundidad, anticoncepcion y planificacion familiar en Mexico.]
  487. Fertility, family planning, and the present and future of birth control: Hungarian congress, October 5-6, 1982. [A termekenyseg, csaladtervezes, szuletesszabalyozas jelene es jovoje: tudomanyos kongresszus, 1982 oktober 5-6.]
  488. Few restrictions in natural family planning [letter]
  489. Fewer abortions: Swedish family planning and abortion in an international perspective. [Farre aborter: svensk familjeplanering och abortlag i ett internationellt perspektiv.]
  490. The fight for family planning.
  491. A fight for women's happiness. Pioneering the family planning movement in Japan.
  492. Final report of the meeting on family planning and the mass media in the 1980s. [Informe final reunion sobre planificacion familiar y los medios masivos de comunicacion.]
  493. Final report, Seminar-Workshop XIII, "Planning and Management of Service Delivery Programs in Family Planning Health and Development", May 7 to June 8, 1984.
  494. Financial resources for maternal/child health and family planning: a global review.
  495. A focused approach to quality of care assessment in family planning.
  496. Follow-up consultancy on information systems of the Indonesian Family Planning Coordinating Board.
  497. Formulation and noncontraceptive uses of the new, low-dose oral contraceptive.
  498. FPIA helps expand contraceptive services.
  499. Freedom to choose: the life and work of Dr. Helena Wright, pioneer of contraception.
  500. Further investigations on the cytological effects of some contraceptives.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.